News | Artificial Intelligence | July 01, 2019

vRad Presents AI Model to Assess Probability of Aortic Dissection

Model presented at SIIM 2019 used to prioritize cases and accelerate time-to-care

vRad Presents AI Model to Assess Probability of Aortic Dissection

July 1, 2019 – vRad (Virtual Radiologic), a Mednax company recently made a scientific presentation, “Screening for Aortic Dissection on CT Angiography Using a Convolutional Neural Network,” at the Society for Imaging Informatics in Medicine (SIIM) Annual Meeting, June 26-28 in Aurora, Colo.

The presentation highlighted how vRad, using machine learning on retrospective aortic dissection data, created an artificial intelligence (AI) model for classifying and prioritizing aortic dissection and rupture for all post-contrast chest computed tomography (CT) imaging data passing through vRad’s patented reading platform. The model is integrated into vRad radiologists’ workflow to accelerate time-to-care. The presentation also outlined how vRad, in conjunction with the Mednax Radiology Solutions Artificial Intelligence (MDR-AI) Incubator, developed a convolutional neural network model trained on these aortic datasets to assess how likely these pathologies would be present in a chest CT.  

Aortic dissection is a condition in which the aorta wall tears, causing blood to flow through the torn region as the middle and inner layers of the wall separate. This condition can be fatal if not recognized and treated immediately. The ideal imaging technique for identification of aortic dissection is computed tomography angiography (CTA) of the aorta. A fast method of screening chest CT studies for this pathology can assist with efficient patient triage and diagnosis.

The work developing the model also includes efforts of the MDR-AI Incubator, which launched in November 2018. The Incubator brings together radiologists, rich clinical datasets and technology partners to stimulate innovation and product development in radiology, improving clinical accuracy, efficiency, and the overall quality of patient care. The AI Incubator’s approach involves developing models that have immediate and measurable impact, so that medical and technical leaders can build tools that improve the practice of radiology for physicians and their patients.

For more information: www.vrad.com

Related Content

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China) #COVID2019 #COVID19 #coronavirus #2019nCoV

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China)

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — The first in a series of medical imaging studies on novel coronavirus (COVID-19) was published on
AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COV
 LucidHealth, a physician-owned and led radiology company, announced today that it is using an AI-powered diagnostic aid from leading AI vendor Aidoc to help prioritize and expedite treatment to patients with critical, life-threatening conditions
News | Artificial Intelligence | February 28, 2020
February 28, 2020 — LucidHealth, a physician-owned and led r
Qure.ai, a leading healthcare AI startup
News | Artificial Intelligence | February 27, 2020
February 27, 2020 — Qure.ai, a leading healthcare AI startup has ann
In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19) #COVID19 #COVID-2019 #2019nCoV #COVID-19

Chest CT images of a 29-year-old man with fever for 6 days. RT-PCR assay for the SARS-CoV-2 using a swab sample was performed on Feb. 5, 2020, with a positive result. (A column) Normal chest CT with axial and coronal planes was obtained at the onset. (B column) Chest CT with axial and coronal planes shows minimal ground-glass opacities in the bilateral lower lung lobes (yellow arrows). (C column) Chest CT with axial and coronal planes shows increased ground-glass opacities (yellow arrowheads). (D column) Chest CT with axial and coronal planes shows the progression of pneumonia with mixed ground-glass opacities and linear opacities in the subpleural area. (E column) Chest CT with axial and coronal planes shows the absorption of both ground-glass opacities and organizing pneumonia. Image courtesy of Radiology

News | Computed Tomography (CT) | February 26, 2020 | Melinda Taschetta-Millane and Dave Fornell
February 26, 2020 — In a study of m
 over the course of a week and a half #coronavirus #COVID19 #COVID-2019 #2019nCoV

29-year old male with unknown exposure history, presenting with fever and cough, ultimately requiring intensive care unit admission. (a) Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass (solid arrows) and consolidative (dashed arrows) pulmonary opacities. (b) The disease in the right middle and lower lobes has a striking peripheral distribution (arrow). Image courtesy of Radiology 

News | Computed Tomography (CT) | February 26, 2020
February 26, 2020 — Mount Sinai Health System physicians—the
Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV) #coronavirus #nCoV2019 #2019nCoV #COVID19

Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV). Three representative axial thin-section chest CT images show multifocal ground glass opacities without consolidation. Three-dimensional volume-rendered reconstruction shows the distribution of the ground-glass opacities (arrows). Image courtesy of the Radiological Society of North America (RSNA)

News | Radiology Imaging | February 25, 2020
February 24, 2020 — The U.S.
Carestream’s state-of-the-art OnSight 3D Extremity System
News | Computed Tomography (CT) | February 25, 2020
February 25, 2020 — Carestream’s state-of-the-art...
Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel